Schizencephaly

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:799OMIM:269160Q04.6
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Schizencephaly is a rare congenital brain malformation characterized by abnormal clefts (splits) lined with gray matter that extend from the surface of the cerebral cortex to the lateral ventricles. These clefts may be unilateral (affecting one side of the brain) or bilateral (affecting both sides) and are classified as either closed-lip (Type I), where the walls of the cleft are in contact with each other, or open-lip (Type II), where the cleft walls are separated and filled with cerebrospinal fluid. The condition results from a disruption in early brain development during neuronal migration, typically occurring between the second and fifth months of gestation. The clinical presentation of schizencephaly varies widely depending on the size, location, and type of the cleft(s). Common symptoms include seizures (epilepsy), motor impairment ranging from mild weakness (hemiparesis) to severe spastic quadriparesis, intellectual disability, and developmental delays in speech and language. Individuals with bilateral open-lip clefts tend to have more severe neurological deficits, while those with small unilateral closed-lip clefts may have milder symptoms, sometimes presenting only with seizures or mild motor difficulties. Hydrocephalus (excess fluid in the brain) may also occur, particularly in open-lip cases. Microcephaly is another associated finding. Most cases of schizencephaly occur sporadically, though mutations in the EMX2 gene have been identified in some familial cases. Environmental factors such as prenatal infections (particularly cytomegalovirus), vascular disruptions, and exposure to teratogens have also been implicated. There is no cure for schizencephaly, and treatment is supportive and symptomatic. Management may include antiepileptic medications for seizure control, physical and occupational therapy for motor impairments, speech therapy for language delays, and in some cases, surgical placement of a shunt to manage hydrocephalus. Prognosis depends on the severity of the malformation and associated complications.

Clinical phenotype terms— hover any for plain English:

Porencephalic cystHP:0002132Spastic tetraplegiaHP:0002510
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Schizencephaly.

View clinical trials →

No actively recruiting trials found for Schizencephaly at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Schizencephaly community →

Specialists

1 foundView all specialists →
CP
Christopher A. Walsh, M.D., Ph.D.
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Schizencephaly.

Search all travel grants →NORD Financial Assistance ↗

Community

Open SchizencephalyForum →

No community posts yet. Be the first to share your experience with Schizencephaly.

Start the conversation →

Latest news about Schizencephaly

No recent news articles for Schizencephaly.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Schizencephaly

What is Schizencephaly?

Schizencephaly is a rare congenital brain malformation characterized by abnormal clefts (splits) lined with gray matter that extend from the surface of the cerebral cortex to the lateral ventricles. These clefts may be unilateral (affecting one side of the brain) or bilateral (affecting both sides) and are classified as either closed-lip (Type I), where the walls of the cleft are in contact with each other, or open-lip (Type II), where the cleft walls are separated and filled with cerebrospinal fluid. The condition results from a disruption in early brain development during neuronal migration,

How is Schizencephaly inherited?

Schizencephaly follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Schizencephaly typically begin?

Typical onset of Schizencephaly is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Schizencephaly?

1 specialists and care centers treating Schizencephaly are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.